# Anticancer Mechanisms of Ginsenoside Compound K: A Review

**Authors:** Yu-Po Lee, Hui-Ting Chan, Tzu-Hsuan Li, Lichieh (Julie) Chu, Sheau-Long Lee, Yu-Quan Chang, Robert YL Wang

PMC · DOI: 10.3390/diseases13050143 · Diseases · 2025-05-05

## TL;DR

This paper reviews the anticancer effects of ginsenoside compound K, focusing on its potential to inhibit cancer cell growth and reduce inflammation.

## Contribution

The paper systematically organizes current research on ginsenoside CK's mechanisms in cancer treatment.

## Key findings

- Ginsenoside CK suppresses cancer cell proliferation and inflammation.
- CK modulates immune response and inhibits angiogenesis in cancer treatment.
- CK protects cardiovascular, hepatic, and renal functions during cancer therapy.

## Abstract

Cancer, also known as malignant tumors, is formed due to abnormal mutations and the proliferation of human cells. Cancer cells not only demonstrate accelerated proliferation but also show robust invasive and metastatic potential, disseminating from a primary affected region of the body to multiple areas and potentially culminating in organ dysfunction or failure, thereby jeopardizing the individual’s life. The rapid growth of the biopharmaceutical market has given rise to numerous novel medicines, thereby precipitating a paradigm shift in contemporary drug development methodologies. This modification is focused on identifying methodologies that can effectively target cancerous cells while minimizing damage to normal cells. There is an increasing societal movement that supports the utilization of natural ingredients derived from plants. In recent years, traditional herbal medicine has experienced a surge in popularity within the global cancer market. In comparison with the use of more toxic chemotherapy methods, there has been an increasing focus on advanced therapies that exhibit reduced side effects. Ginsenoside compound K (CK) is derived from the natural components in ginseng through biotransformation. The utilization of CK in cancer research is a practice engaged in by numerous scientists. The underlying rationale is that CK exhibits a multitude of effects within the realm of cancer research, including but not limited to the mitigation of inflammation, the suppression of cancerous cell proliferation, and the safeguarding of cardiovascular, hepatic, and renal functions. This review methodically identifies and organizes CK-related journals according to the following key points of cancer treatment: the effects on cancer cells themselves, angiogenesis inhibition, modulation of immune response to identify cancer cells, and inflammation regulation. The intricate interplay between ginsenoside CK and cells is elucidated through a graphical representation. The present review focuses on the results of CK in in vitro tests. It is our hope that the present article will aid future studies on the results of CK in vivo tests, clarify the correlation between cellular mechanisms in vivo and in vitro tests, and assist in the development of drugs.

## Linked entities

- **Chemicals:** ginsenoside compound K (PubChem CID 9852086), ginsenoside CK (PubChem CID 9852086)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Cancer (MESH:D009369), organ dysfunction or failure (MESH:D009102), inflammation (MESH:D007249)
- **Chemicals:** CK (MESH:C112772)
- **Species:** Homo sapiens (human, species) [taxon 9606], Panax ginseng (Asiatic ginseng, species) [taxon 4054]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12110123/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12110123/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC12110123/full.md

---
Source: https://tomesphere.com/paper/PMC12110123